183 related articles for article (PubMed ID: 1884565)
1. Telangiectatic osteogenic sarcoma of the extremities. Results in 17 patients treated with neoadjuvant chemotherapy.
Pignatti G; Bacci G; Picci P; Dallari D; Bertoni F; Bacchini P; Capanna R
Clin Orthop Relat Res; 1991 Sep; (270):99-106. PubMed ID: 1884565
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremities.
Bacci G; Picci P; Pignatti G; De Cristofaro R; Dallari D; Avella M; Manfrini M; Marangolo M; Ferruzzi A; Mercuri M
Clin Orthop Relat Res; 1991 Sep; (270):87-98. PubMed ID: 1884564
[TBL] [Abstract][Full Text] [Related]
3. Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for telangiectatic osteogenic sarcoma of the extremities.
Bacci G; Pignatti G; Dallari D; Mercuri M; Bertoni F; Bacchini P; Fontana M; Avella M; Campanacci M
J Chemother; 1989 Jun; 1(3):190-6. PubMed ID: 2477510
[TBL] [Abstract][Full Text] [Related]
4. Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin.
Bacci G; Picci P; Ferrari S; Ruggieri P; Casadei R; Tienghi A; Brach del Prever A; Gherlinzoni F; Mercuri M; Monti C
Cancer; 1993 Dec; 72(11):3227-38. PubMed ID: 8242546
[TBL] [Abstract][Full Text] [Related]
5. Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Istituto Rizzoli Experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatin.
Bacci G; Picci P; Ruggieri P; Mercuri M; Avella M; Capanna R; Brach Del Prever A; Mancini A; Gherlinzoni F; Padovani G
Cancer; 1990 Jun; 65(11):2539-53. PubMed ID: 2337871
[TBL] [Abstract][Full Text] [Related]
6. Primary chemotherapy and delayed surgery for non-metastatic telangiectatic osteosarcoma of the extremities. Results in 28 patients.
Bacci G; Picci P; Ferrari S; Sangiorgi L; Zanone A; Brach del Prever A
Eur J Cancer; 1994; 30A(5):620-6. PubMed ID: 8080676
[TBL] [Abstract][Full Text] [Related]
7. Combined pre-operative chemotherapy with intra-arterial cisplatin and continuous intravenous adriamycin for high grade osteosarcoma.
Rha SY; Chung HC; Gong SJ; Shim KY; Ahn JB; Yang WI; Shin KH; Yoo NC; Kim JH; Roh JK; Lee CI; Kim BS
Oncol Rep; 1999; 6(3):631-7. PubMed ID: 10203605
[TBL] [Abstract][Full Text] [Related]
8. Impact of two cycles of preoperative chemotherapy with intraarterial cisplatin and intravenous doxorubicin on the choice of surgical procedure for high-grade bone sarcomas of the extremities.
Malawer M; Buch R; Reaman G; Priebat D; Potter B; Khurana J; Shmookler B; Patterson K; Schulof R
Clin Orthop Relat Res; 1991 Sep; (270):214-22. PubMed ID: 1884542
[TBL] [Abstract][Full Text] [Related]
9. Limb-sparing in patients with non-metastatic high-grade osteosarcoma.
Samardziski M; Zafiroski G; Tolevska C; Zafirova-Ivanovska B; Kostadinova-Kunovska S; Kalicanin-Markovska M
J BUON; 2009; 14(1):63-9. PubMed ID: 19373949
[TBL] [Abstract][Full Text] [Related]
10. Current management, local management, and survival statistics of high-grade osteosarcoma. Experience in Japan.
Ogihara Y; Sudo A; Fujinami S; Sato K; Miura T
Clin Orthop Relat Res; 1991 Sep; (270):72-8. PubMed ID: 1884562
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy in the treatment of osteosarcoma of the extremities: preliminary results in 131 cases treated preoperatively with methotrexate and cisdiamminoplatinum.
Bacci G; Avella M; Capanna R; Boriani S; Dallari D; Galletti S; Giunti A; Madon E; Mancini A; Mercuri M
Ital J Orthop Traumatol; 1988 Mar; 14(1):23-39. PubMed ID: 3235324
[TBL] [Abstract][Full Text] [Related]
12. Telangiectatic osteosarcoma of the extremity: neoadjuvant chemotherapy in 24 cases.
Bacci G; Ferrari S; Ruggieri P; Biagini R; Fabbri N; Campanacci L; Bacchini P; Longhi A; Forni C; Bertoni F
Acta Orthop Scand; 2001 Apr; 72(2):167-72. PubMed ID: 11372948
[TBL] [Abstract][Full Text] [Related]
13. High dose ifosfamide in combination with high dose methotrexate, adriamycin and cisplatin in the neoadjuvant treatment of extremity osteosarcoma: preliminary results of an Italian Sarcoma Group/Scandinavian Sarcoma Group pilot study.
Bacci G; Ferrari S; Longhi A; Picci P; Mercuri M; Alvegard TA; Saeter G; Donati D; Manfrini M; Lari S; Briccoli A; Forni C;
J Chemother; 2002 Apr; 14(2):198-206. PubMed ID: 12017378
[TBL] [Abstract][Full Text] [Related]
14. The effect of intra-arterial versus intravenous cisplatinum in the neoadjuvant treatment of osteosarcoma of the limbs: the experience at the Rizzoli Institute.
Bacci G; Ferrari S; Forni C; Mercuri M; Picci P; Bertoni F; Capanna R; Manfrini M; Donati D; Brach Del Prever A; Baldini N
Chir Organi Mov; 1996; 81(4):369-82. PubMed ID: 9147928
[TBL] [Abstract][Full Text] [Related]
15. The importance of dose-intensity in neoadjuvant chemotherapy of osteosarcoma: a retrospective analysis of high-dose methotrexate, cisplatinum and adriamycin used preoperatively.
Bacci G; Picci P; Avella M; Dallari D; Ferrari S; Prasad R; Di Scioscio M; Malaguti C; Caldora P
J Chemother; 1990 Apr; 2(2):127-35. PubMed ID: 2362188
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated report.
Bacci G; Ferrari S; Bertoni F; Ruggieri P; Picci P; Longhi A; Casadei R; Fabbri N; Forni C; Versari M; Campanacci M
J Clin Oncol; 2000 Dec; 18(24):4016-27. PubMed ID: 11118462
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemotherapy for osseous malignant fibrous histiocytoma of the extremity: results in 18 cases and comparison with 112 contemporary osteosarcoma patients treated with the same chemotherapy regimen.
Bacci G; Ferrari S; Bertoni F; Mercuri M; Forni C; Sottili S; Gasbarrini A; Tienghi A; Cesari M; Campanacci M
J Chemother; 1997 Aug; 9(4):293-9. PubMed ID: 9269611
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: long-term results for patients treated according to the Rizzoli IOR/OS-3b protocol.
Bacci G; Ferrari S; Longhi A; Forni C; Bertoni F; Fabbri N; Zavatta M; Versari M
J Chemother; 2001 Feb; 13(1):93-9. PubMed ID: 11233808
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant high-dose methotrexate, cisplatin, and doxorubicin for the management of patients with nonmetastatic osteosarcoma.
Weiner MA; Harris MB; Lewis M; Jones R; Sherry H; Feurer EJ; Johnson J; Lahman E
Cancer Treat Rep; 1986 Dec; 70(12):1431-2. PubMed ID: 3466693
[No Abstract] [Full Text] [Related]
20. Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: is a good response to preoperative treatment an indication to reduce postoperative chemotherapy?
Bacci G; Picci P; Gherlinzoni F; Van Horn JR; Orlandi M; Normand AR; Manfrini M; Pignatti G; Campanacci M
Chemioterapia; 1986 Apr; 5(2):140-3. PubMed ID: 3458546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
